Geneva Advisors’s CyrusOne Inc Common Stock CONE Stock Holding History

Geneva Advisors’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$89.5M	Sell	1,605,126 -1,035	-0.1%	-$57.2K	1.54%	13
2017 Q1	$82.7M	Sell	1,606,161 -8,322	-0.5%	-$409K	1.48%	13
2016 Q4	$72.2M	Sell	1,614,483 -44,912	-3%	-$1.99M	1.41%	17
2016 Q3	$78.9M	Sell	1,659,395 -6,183	-0.4%	-$320K	1.48%	14
2016 Q2	$92.7M	Sell	1,665,578 -116,034	-7%	-$5.59M	1.83%	10
2016 Q1	$81.3M	Buy	1,781,612 +54,268	+3%	+$2.07M	1.64%	13
2015 Q4	$64.7M	Sell	1,727,344 -13,107	-0.8%	-$463K	1.24%	26
2015 Q3	$56.8M	Sell	1,740,451 -71,992	-4%	-$2.29M	1.15%	29
2015 Q2	$53.4M	Buy	1,812,443 +684,879	+61%	+$21.4M	0.95%	41
2015 Q1	$35.1M	Buy	+1,127,564	New	+$33.3M	0.63%	54

Other funds holding CONE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CIMLRA

CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return

Geneva Advisors's CONE Position: Q2 2017 in Review

Geneva Advisors reduced its CyrusOne Inc Common Stock (CONE) stake by 0.06% in Q2 2017, selling an estimated $57.2K and leaving 1,605,126 shares worth $89.5M. The position accounts for 1.54% of the portfolio, ranked #13.

Geneva Advisors first reported a position in CONE in Q1 2015 and has held it in 10 quarters since. The position peaked at $92.7M in Q2 2016. 300 funds tracked by Wall St. Rank hold CONE as of Q2 2017.

Geneva Advisors held 1,605,126 shares of CyrusOne Inc Common Stock worth $89.5M as of Q2 2017.
Geneva Advisors sold 1,035 CyrusOne Inc Common Stock shares in Q2 2017, an estimated $57.2K.
CyrusOne Inc Common Stock made up 1.54% of Geneva Advisors's portfolio in Q2 2017, its #13 holding.
Geneva Advisors first reported a position in CyrusOne Inc Common Stock in Q1 2015 and has held it in 10 quarters since.
Geneva Advisors's CyrusOne Inc Common Stock position peaked at $92.7M in Q2 2016.
300 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.